EU Says it has Secured Nearly Half of Pfizer's 2021 Global COVID-19 Vaccine Production

Click the image below to enlarge the infographic.
  • The European Union has reached a deal with Pfizer and BioNTech to acquire 300 million additional doses of their COVID-19 vaccine, the head of the European Commission announced Friday
  • This move would give the EU nearly half of the firm's global vaccine output for 2021
  • Pfizer said it can produce up to 1.3 billion doses this year, and the new agreement with the EU has secured 600 million vaccine doses for the region
  • Pfizer has also agreed to sell the US up to 600 million doses of the vaccine, of which 200 million have already been ordered
  • Germany also said it will make a side seal with the drug firm to supply 30 million additional doses, in contrast to EU agreements that forbid members to negotiate parallel deals with vaccine makers